183 related articles for article (PubMed ID: 30832648)
21. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes.
Shihab F; Christians U; Smith L; Wellen JR; Kaplan B
Transpl Immunol; 2014 Jun; 31(1):22-32. PubMed ID: 24861504
[TBL] [Abstract][Full Text] [Related]
22. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.
Yao J; Wei C; Wang JY; Zhang R; Li YX; Wang LS
World J Gastroenterol; 2015 Jun; 21(21):6572-81. PubMed ID: 26074695
[TBL] [Abstract][Full Text] [Related]
23. Effect of Mammalian Target of Rapamycin Inhibition on Activated Regulatory T-Cell Expansion in Kidney Transplantation.
Tomita Y; Uehara S; Takiguchi S; Nakamura M
Transplant Proc; 2023 May; 55(4):792-796. PubMed ID: 37100735
[TBL] [Abstract][Full Text] [Related]
24. Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Ori Y; Herman-Edelstein M; Zingerman B; Rozen-Zvi B; Gafter U; Malachi T; Gafter-Gvili A
Biomed Pharmacother; 2012 Sep; 66(6):409-13. PubMed ID: 22795807
[TBL] [Abstract][Full Text] [Related]
25. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients.
Lemaitre F; Antignac M; Fernandez C
Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394
[TBL] [Abstract][Full Text] [Related]
26. The impact of portal infusion with donor-derived bone marrow cells and intracellular cytokine expression of graft-infiltrating lymphocytes on the graft survival in rat small bowel transplant model.
Mitsuoka N; Iwagaki H; Ozaki M; Sheng SD; Sadamori H; Matsukawa H; Morimoto Y; Matsuoka J; Tanaka N; Yagi T
Transpl Immunol; 2004 Nov; 13(3):155-60. PubMed ID: 15381197
[TBL] [Abstract][Full Text] [Related]
27. Anthocyanin Extracted from Black Soybean Seed Coats Prevents Autoimmune Arthritis by Suppressing the Development of Th17 Cells and Synthesis of Proinflammatory Cytokines by Such Cells, via Inhibition of NF-κB.
Min HK; Kim SM; Baek SY; Woo JW; Park JS; Cho ML; Lee J; Kwok SK; Kim SW; Park SH
PLoS One; 2015; 10(11):e0138201. PubMed ID: 26544846
[TBL] [Abstract][Full Text] [Related]
28. Metformin attenuates graft-versus-host disease via restricting mammalian target of rapamycin/signal transducer and activator of transcription 3 and promoting adenosine monophosphate-activated protein kinase-autophagy for the balance between T helper 17 and Tregs.
Park MJ; Lee SY; Moon SJ; Son HJ; Lee SH; Kim EK; Byun JK; Shin DY; Park SH; Yang CW; Cho ML
Transl Res; 2016 Jul; 173():115-130. PubMed ID: 27126953
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
Yago T; Nanke Y; Kawamoto M; Yamanaka H; Kotake S
Cytokine; 2012 Aug; 59(2):252-7. PubMed ID: 22579702
[TBL] [Abstract][Full Text] [Related]
31. Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
Wowro SJ; Schmitt KRL; Tong G; Berger F; Schubert S
Int Immunopharmacol; 2016 Jan; 30():9-17. PubMed ID: 26613512
[TBL] [Abstract][Full Text] [Related]
32. Intracellular tacrolimus concentration correlates with impaired renal function through regulation of the IS-AHR-ABC transporter in peripheral blood mononuclear cells.
Guo P; Zhang R; Zhou J; Li P; Liu Y; Shi S
Int Immunopharmacol; 2024 Jan; 126():111233. PubMed ID: 37979449
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal stem cells and a vitamin D receptor agonist additively suppress T helper 17 cells and the related inflammatory response in the kidney.
Duffy MM; McNicholas BA; Monaghan DA; Hanley SA; McMahon JM; Pindjakova J; Alagesan S; Fearnhead HO; Griffin MD
Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1412-26. PubMed ID: 25339699
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
35. mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile.
Hu S; Chen M; Wang Y; Wang Z; Pei Y; Fan R; Liu X; Wang L; Zhou J; Zheng S; Zhang T; Lin Y; Zhang M; Tao R; Zhong J
PLoS One; 2016; 11(4):e0154564. PubMed ID: 27128484
[TBL] [Abstract][Full Text] [Related]
36. Time-Dependent and Immunosuppressive Drug-Associated Adverse Event Profiles in De Novo Kidney Transplant Recipients Converted from Tacrolimus to Sirolimus Regimens.
Felix MJ; Felipe CR; Tedesco-Silva H; Osmar Medina-Pestana J
Pharmacotherapy; 2016 Feb; 36(2):152-65. PubMed ID: 26799522
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of Tregs and Th17/Th1 cells by a sirolimus-based regimen might be dependent on STAT-signaling in renal transplant recipients.
Li Y; Shi Y; Liao Y; Yan L; Zhang Q; Wang L
Int Immunopharmacol; 2015 Sep; 28(1):435-43. PubMed ID: 26186486
[TBL] [Abstract][Full Text] [Related]
38. Activity of the Calcineurin Pathway in Patients on the Liver Transplantation Waiting List: Factors of Variability and Response to Tacrolimus Inhibition.
Noceti O; Pouché L; Esperón P; Lens D; Vital M; Touriño C; Gerona S; Woillard JB; Marquet P
Clin Chem; 2017 Nov; 63(11):1734-1744. PubMed ID: 29054923
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of the two amino acid sensing systems, the GCN2 kinase and the mTOR complex 1, on primary human alloreactive CD4⁺ T-cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Tsogka K; Sounidaki M; Stefanidis I
Int J Mol Med; 2016 May; 37(5):1412-20. PubMed ID: 27035541
[TBL] [Abstract][Full Text] [Related]
40. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
Helmschrott M; Rivinius R; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2017; 11():1673-1680. PubMed ID: 28652705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
